Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS). (Q43979288)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS). |
scientific article |
Statements
1 reference
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS). (English)
1 reference
1 reference
1 reference
Sumitra Thongprasert
1 reference
Emma Duffield
1 reference
Nagahiro Saijo
1 reference
Da-Tong Chu
1 reference
Meilin Liao
1 reference
Yuh-Min Chen
1 reference
Han-Pin Kuo
1 reference
Shunichi Negoro
1 reference
Kwok Chi Lam
1 reference
Alison Armour
1 reference
Patrick Magill
1 reference
Masahiro Fukuoka
1 reference
1 November 2011
1 reference
1 reference
6
1 reference
11
1 reference
1872-1880
1 reference
Identifiers
1 reference
1 reference